112 related articles for article (PubMed ID: 11575562)
1. In vitro effects of fluoride on pseudocholinesterase activity and the metabolism of the cis-trans and trans-trans isomers of mivacurium.
Wiesner G; Gruber M; Keyl C; Schneider A; Drescher J; Hobbhahn J
Anesthesiology; 2001 Sep; 95(3):806-7. PubMed ID: 11575562
[No Abstract] [Full Text] [Related]
2. The effect of fluoride and hypothermia on the in vitro metabolism of mivacurium.
Gruber M; Lindner R; Prasser C; Wiesner G
Anesth Analg; 2002 Aug; 95(2):397-9, table of contents. PubMed ID: 12145059
[TBL] [Abstract][Full Text] [Related]
3. Pseudocholinesterase-mediated hydrolysis is superior to neostigmine for reversal of mivacurium-induced paralysis in vitro.
Yang HS; Goudsouzian N; Martyn JA
Anesthesiology; 1996 Apr; 84(4):936-44. PubMed ID: 8638849
[TBL] [Abstract][Full Text] [Related]
4. [Prolonged mivacurium induced neuromuscular block in 5 patients homozygotic for atypical butyrylcholinesterase phenotype].
Burnat P; Soulard D; Jacquel A; Coste T; Le Marchand P; Benoist JF
Ann Fr Anesth Reanim; 1995; 14(6):532. PubMed ID: 8745981
[No Abstract] [Full Text] [Related]
5. Cholinesterase inhibition by potato glycoalkaloids slows mivacurium metabolism.
McGehee DS; Krasowski MD; Fung DL; Wilson B; Gronert GA; Moss J
Anesthesiology; 2000 Aug; 93(2):510-9. PubMed ID: 10910502
[TBL] [Abstract][Full Text] [Related]
6. Edrophonium requirements for reversal of deep neuromuscular block following infusion of mivacurium.
Miller DR; Bryson G; Martineau RJ; Kitts JB; Curran M; Bragg P; Watson JB; Hull K; Lindsay P
Can J Anaesth; 1995 Nov; 42(11):996-1002. PubMed ID: 8590511
[TBL] [Abstract][Full Text] [Related]
7. [Prolonged neuromuscular block after administration of mivacurium caused by plasma psueudocholinesterase deficiency].
Kaiser E; Petit D; Quinot JF; Suppini A; Sallaberry M
Ann Fr Anesth Reanim; 1995; 14(6):505-7. PubMed ID: 8745975
[TBL] [Abstract][Full Text] [Related]
8. [Cholinesterases].
Lejus C; Blanloeil Y; Burnat P; Souron R
Ann Fr Anesth Reanim; 1998; 17(9):1122-35. PubMed ID: 9835982
[TBL] [Abstract][Full Text] [Related]
9. [Value of the monitoring of curarisation during prolonged mivacurium induced neuromuscular block].
Avargues P; Cros AM; Dardel E; Darriet M; Biteau N
Ann Fr Anesth Reanim; 1995; 14(6):511-3. PubMed ID: 8745977
[TBL] [Abstract][Full Text] [Related]
10. [Prolonged neuromuscular block after mivacurium injection].
Viggiano M; Soler C; Dumont JC; Pellissier D; François G
Ann Fr Anesth Reanim; 1995; 14(6):502-4. PubMed ID: 8745974
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics and pharmacodynamics of the stereoisomers of mivacurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia.
Lien CA; Schmith VD; Embree PB; Belmont MR; Wargin WA; Savarese JJ
Anesthesiology; 1994 Jun; 80(6):1296-302. PubMed ID: 8010476
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamics and the plasma concentration of mivacurium during spontaneous recovery and neostigmine-facilitated recovery.
Lien CA; Belmont MR; Wray Roth DL; Okamoto M; Abalos A; Savarese JJ
Anesthesiology; 1999 Jul; 91(1):119-26. PubMed ID: 10422936
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the enzymic degradation of suxamethonium and mivacurium increases the onset time of submaximal neuromuscular block.
Beaufort TM; Nigrovic V; Proost JH; Houwertjes MC; Wierda JM
Anesthesiology; 1998 Sep; 89(3):707-14. PubMed ID: 9743409
[TBL] [Abstract][Full Text] [Related]
14. [Mivacurium and prolonged curarization].
Meistelman C
Ann Fr Anesth Reanim; 1995; 14(6):463-4. PubMed ID: 8745967
[No Abstract] [Full Text] [Related]
15. Stereoselective high-performance liquid chromatographic assay with fluorometric detection of the three isomers of mivacurium and their cis- and trans-alcohol and ester metabolites in human plasma.
Biederbick W; Aydinciouglou G; Diefenbach C; Theisohn M
J Chromatogr B Biomed Appl; 1996 Oct; 685(2):315-22. PubMed ID: 8953173
[TBL] [Abstract][Full Text] [Related]
16. The influence of drug-induced low plasma cholinesterase activity on the pharmacokinetics and pharmacodynamics of mivacurium.
Ostergaard D; Rasmussen SN; Viby-Mogensen J; Pedersen NA; Boysen R
Anesthesiology; 2000 Jun; 92(6):1581-7. PubMed ID: 10839906
[TBL] [Abstract][Full Text] [Related]
17. Cholinesterase inhibitors do not prolong neuromuscular block produced by mivacurium.
Fleming NW; Lewis BK
Br J Anaesth; 1994 Aug; 73(2):241-3. PubMed ID: 7917744
[TBL] [Abstract][Full Text] [Related]
18. Response to mivacurium in a patient compound heterozygous for a novel and a known silent mutation in the butyrylcholinesterase gene: genotyping by sequencing.
Gätke MR; Ostergaard D; Bundgaard JR; Varin F; Viby-Mogensen J
Anesthesiology; 2001 Sep; 95(3):600-6. PubMed ID: 11575530
[TBL] [Abstract][Full Text] [Related]
19. Prolonged neuromuscular block associated with mivacurium.
Fox MH; Hunt PC
Br J Anaesth; 1995 Feb; 74(2):237-8. PubMed ID: 7696077
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of the three isomers of mivacurium and pharmacodynamics of the chiral mixture in hepatic cirrhosis.
Head-Rapson AG; Devlin JC; Parker CJ; Hunter JM
Br J Anaesth; 1994 Nov; 73(5):613-8. PubMed ID: 7826789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
